Intelligent delivery of autophagy-targeting chimeric peptides by engineered exosomes for the degradation of α-synuclein
Acta Biomaterialia · 2026-05 · 215 · 288-301
DOI: 10.1016/j.actbio.2026.04.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-05. Verfasst von Yuteng Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, College of Pharmaceutical Sciences, Soochow University, Suzho…. Hauptthemen laut MEDLINE: alpha-Synuclein, Exosomes, Autophagy, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Priority Academic Program Development of Jiangsu Higher Education Institutions, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Targeted degradation of the aggregated α-synuclein holds tremendous potential for treating Parkinson's disease (PD). However, most of the developed aggregated α-synuclein-specific degraders, e.g., autophagy-targeting chimeric peptides, are limited by the blood-brain barrier (BBB), substantia nigra (SN) neuron targetability, and intracytoplasmic release. To overcome these obstacles, we constructed an engineered exosome (EXO) equipped with surficial glucose-regulated protein 94 (GRP94)-targeting peptide N, luminal α-synuclein-degrading peptide P1, and cathepsin-B-cleavable GFLG as the linker between the exosome skeleton protein and P1, termed NEXOGFLG-P1. We verified that the NEXOGFLG-P1 exosomes could cross the BBB and target diseased SN neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP)-induced PD model mice. Following fusion with endosomes, the exposed P1 was released into the cytoplasm by cytoplasmic cathepsin B-mediated GFLG cleavage to degrade α-synuclein. Collectively, the NEXOGFLG-P1 exosomes exhibit a significant degradation effect on α-synuclein aggregates, providing a proof-of-concept platform for treating PD. STATEMENT OF SIGNIFICANCE: Targeted degradation of α-synuclein aggregates holds tremendous potential for the etiological treatment of Parkinson's disease (PD). However, most of current α-synuclein-specific degraders are stuck with low blood-brain barrier permeability, poor targetability for diseased cells, and uncontrolled release. Notably, α-synuclein predominantly affects neurons in the substantia nigra (SN) region rather than the whole brain. To overcome these obstacles, we constructed an engineered exosome, termed NEXOGFLG-P1, to specially deliver and release autophagy-targeting chimeric peptide to degrade α-synuclein in the diseased SN neurons through the autophagy-lysosomal pathway. The engineered exosomes exhibit the great potential in targeting diseased SN neurons and degrading α-synuclein aggregates, providing a proof-of-concept therapeutic platform for treating PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China.
- Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China; Jiangsu Province Engineering Research Center…
Förderung
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Zeng, Y., Lv, Z., Liang, J., Wu, Y., & Han, L. (2026). Intelligent delivery of autophagy-targeting chimeric peptides by engineered exosomes for the degradation of α-synuclein. Acta Biomaterialia, 215, 288-301. https://doi.org/10.1016/j.actbio.2026.04.003
Vancouver
Zeng Y, Lv Z, Liang J, Wu Y, Han L. Intelligent delivery of autophagy-targeting chimeric peptides by engineered exosomes for the degradation of α-synuclein. Acta Biomaterialia. 2026;215:288-301. doi:10.1016/j.actbio.2026.04.003
BibTeX
@article{Zeng2026,
author = {Zeng, Yuteng and Lv, Ziyan and Liang, Jiayu and Wu, Yetao and Han, Liang},
title = {Intelligent delivery of autophagy-targeting chimeric peptides by engineered exosomes for the degradation of α-synuclein},
journal = {Acta Biomaterialia},
year = {2026},
volume = {215},
pages = {288--301},
doi = {10.1016/j.actbio.2026.04.003}
}
EUVIMED